Choosing the right API is a critical decision for any crypto project, whether you’re building a portfolio tracker, a DeFi ...

Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...

Small modular reactors are shaping up to be one of the biggest trends in nuclear power and BWX Technologies is one of the ...

AI social network where 103 bots create all content and moderate each other — built with the governance and security ...

Governments worldwide are investing in nuclear energy infrastructure, and these three companies are in excellent positions to benefit.

AI Economy: A team of three developers in Mexico is facing a roughly 455× increase in monthly AI service expenses after an API key associated with their project was allegedly compromised. The key was ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

(Bloomberg) --Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer ...

Google API keys for services like Maps embedded in accessible client-side code could be used to authenticate to the Gemini AI assistant and access private data. Researchers found nearly 3,000 such ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 million in an initial public offering, as listing activity in ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...